Scer\GAL4TIGS-2 drives expression in the digestive tract, but not in the fat body.
Scer\GAL4TIGS-2 drives mifepristone-inducible expression in the pupal/adult digestive system.
decreased occurrence of cell division | adult stage, with Rpc160GD4257
long lived, with Maf1UAS.Tag:HA
long lived, with Rpc53KK101216
long lived, with Rpc160GD4257
long lived, with srlUAS.cRa
long lived | RU486 conditional, with AhcyL1HM05009
long lived | RU486 conditional, with AhcyL2HMJ23469
short lived, with pntP1.UAS
short lived | RU486 conditional, with STUB1UAS.cAa
adult midgut epithelium, with Rpc160GD4257
Scer\GAL4TIGS-2, pntP1.UAS has short lived phenotype, enhanceable by Scer\GAL4TIGS-2/foxoUAS.cFa
Scer\GAL4TIGS-2, foxoUAS.cFa, pntP1.UAS has short lived phenotype, suppressible | partially by Scer\GAL4TIGS-2/aopACT.UAS
Scer\GAL4TIGS-2/foxoUAS.cFa is an enhancer of short lived phenotype of Scer\GAL4TIGS-2, pntP1.UAS
Scer\GAL4TIGS-2/aopACT.UAS is a suppressor | partially of short lived phenotype of Scer\GAL4TIGS-2, foxoUAS.cFa, pntP1.UAS
The Scer\GAL4TIGS-2 driver shows no evidence of leakiness during the embryonic, larval or pupal stages (it does not drive expression of a UAS transgene in the absence of RU486 during these stages).